Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers (Q40425901)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers |
scientific article |
Statements
1 reference
Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers. (English)
1 reference
1 reference
Ramesh K Ramanathan
1 reference
Donald L Trump
1 reference
Julie L Eiseman
1 reference
Sanjiv S Agarwala
1 reference
Eleanor G Zuhowski
1 reference
Jing Lan
1 reference
Douglas M Potter
1 reference
S Percy Ivy
1 reference
Sakkaraiappan Ramalingam
1 reference
Adam M Brufsky
1 reference
Michael K K Wong
1 reference
Susan Tutchko
1 reference
Merrill J Egorin
1 reference
1 May 2005
1 reference
1 reference
3385-3391
1 reference
Identifiers
1 reference